|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| OPERATING ACTIVITIES | |||||
| Net income | |||||
| Adjustments to reconcile net income to net cash provided by operating activities: | |||||
| Provision for credit losses | |||||
| Depreciation and amortization expense | |||||
| Amortization expense of core deposit intangible | |||||
| Amortization of fair value adjustment on acquired time deposits | |||||
| Net (accretion) amortization of investment securities | |||||
| Net realized losses on investment securities - available for sale | |||||
| Net amortization of deferred loan fees | |||||
| Net gains on loans held for sale | |||||
| Origination of mortgage loans held for sale | |||||
| Sales of mortgage loans held for sale | |||||
| (Increase) decrease in accrued interest receivable | |||||
| Increase (decrease) in accrued interest payable | |||||
| Earnings on bank owned life insurance | |||||
| Deferred income taxes | |||||
| Stock compensation expense | |||||
| Common stock issuable | |||||
| Net change in trading securities | |||||
| Net change in operating leases | |||||
| Other, net | |||||
| Net cash provided by operating activities | |||||
| INVESTING ACTIVITIES | |||||
| Purchase of investment securities - available for sale | |||||
| Purchase of investment securities - held to maturity | |||||
| Proceeds from maturities of investment securities - available for sale | |||||
| Proceeds from maturities of investment securities - held to maturity | |||||
| Proceeds from sale of investment securities - available for sale | |||||
| Purchase of regulatory stock | |||||
| Proceeds from redemption of regulatory stock | |||||
| Long-term loans originated | |||||
| Principal collected on long-term loans | |||||
| Net decrease (increase) in loans | |||||
| Purchase of premises and equipment | |||||
| Proceeds from sale of other real estate owned and repossessed assets | |||||
| Proceeds from life insurance policies | |||||
| Net cash provided by (used in) investing activities | |||||
| FINANCING ACTIVITIES | |||||
| Net increase in deposit balances | |||||
| Net decrease in other short-term borrowings | |||||
| Principal borrowings on advances from Federal Home Loan Bank | |||||
| Principal repayments on advances from Federal Home Loan Bank | |||||
| Principal payments on financing lease liabilities | |||||
| Stock options exercised | |||||
| Purchases of treasury stock | |||||
| Common stock dividend paid | |||||
| Net cash provided by financing activities | |||||
| NET INCREASE IN CASH AND CASH EQUIVALENTS | |||||
| CASH AND CASH EQUIVALENTS AT JANUARY 1 | |||||
| CASH AND CASH EQUIVALENTS AT DECEMBER 31 | |||||
Loading...